BRAINSTORM CELL THERAPEUTICS INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -126.4% | -126.4% | -83.5% |
| FY2022 | 805.2% | 805.2% | -287.3% |
| FY2023 | 353.9% | 353.9% | -408.6% |
| FY2024 | 149.7% | 149.7% | -634.4% |
| FY2025 | 103.2% | 103.2% | -1,008.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -126.4% | -126.4% | -83.5% |
| FY2022 | 805.2% | 805.2% | -287.3% |
| FY2023 | 353.9% | 353.9% | -408.6% |
| FY2024 | 149.7% | 149.7% | -634.4% |
| FY2025 | 103.2% | 103.2% | -1,008.5% |